Global Gastric Volvulus Treatment Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 26.99 Billion |
 Market Size (Forecast Year) |
USD 38.67 Billion |
 CAGR |
% |
| Major Markets Players |
Global Gastric Volvulus Treatment Market, By Type (Organo-Axial Volvulus and Mesentero-Axial Volvulus), Treatment Type (Medication and Surgery), Drugs (Analgesics, Antiemetic Agents, and Others), Route of Administration (Oral and Parenteral), End- User (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy and Retail Pharmacy) – Industry Trends and Forecast to 2031.
Gastric Volvulus Treatment Market Analysis and Size
The gastric volvulus treatment market is witnessing significant advancements, offering benefits such as minimally invasive procedures, improved diagnostic techniques, and enhanced surgical interventions. These innovations are revolutionizing patient care, leading to better outcomes, reduced recovery times, and increased treatment efficacy. As a result, the market is experiencing a surge in demand, driving growth and opportunities for both patients and healthcare providers.
The global gastric volvulus treatment market size was valued at USD 26.99 billion in 2023, is projected to reach USD 38.67 billion by 2031, with a CAGR of 4.6% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (Organo-Axial Volvulus and Mesentero-Axial Volvulus), Treatment Type (Medication and Surgery), Drugs (Analgesics, Antiemetic Agents, and Others), Route of Administration (Oral and Parenteral), End- User (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy and Retail Pharmacy) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America |
|
Market Players Covered |
Sawai Pharmaceutical Co., Ltd (Japan), PAI Pharma (U.S.), Sun Pharmaceutical Industries Ltd (India), ANI Pharmaceuticals, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Mayne Pharma Group Limited (Australia), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Tris Pharma, Inc. (U.S.), Pfizer Inc (U.S.), Mallinckrodt (U.K.), Mylan N.V. (U.S.), GSK plc (U.K.), Par Pharmaceutical. (U.S.), Vintage Labs (India), and Zydus Group (India) |
|
Market Opportunities |
|
Market Definition
Gastric volvulus, a rare condition where the stomach twists abnormally, often require prompt medical attention. Treatment typically involves stabilizing the patient, decompressing the stomach to relieve pressure, and correcting the twist either through endoscopic or surgical intervention. Surgery may involve gastropexy to secure the stomach in its proper position and prevent recurrence. Post-treatment, patients may need dietary modifications and monitoring for complications.
Gastric Volvulus Treatment Market Dynamics
Drivers
- Increasing Prevalence of Gastric Volvulus Treatment
The surge in gastric volvulus cases, fueled by aging populations, shifting lifestyles, and dietary patterns, spur demand for treatment solutions, particularly in regions such as the U.S., with growing elderly populations. For instance, in developed countries such as the U.S., and the elderly population expands, gastric volvulus cases increase, underscoring the demand for tailored healthcare interventions. Effective treatment solutions must be developed to meet the evolving needs of this demographic.
- Advancements in Diagnostic Technologies
Gastric volvulus symptoms, such as severe abdominal pain, chest discomfort, difficulty swallowing, and recurrent vomiting, often mimic other gastrointestinal conditions, making diagnosis challenging. However, advancements in diagnostic technologies such as CT scans, endoscopy, and barium swallow studies enable precise visualization of gastric anatomy, facilitating early detection. This capability is crucial for timely intervention, improving patient outcomes, and propelling the demand for effective treatment options in the market.
Opportunities
- Rising Government Initiatives and Healthcare Reforms
Government policies, reimbursement schemes, and healthcare reforms significantly enhance treatment accessibility for gastric volvulus, ensuring patients receive timely and effective medical care, thereby improving outcomes and reducing healthcare disparities. For instance, the introduction of reimbursement programs covering minimally invasive surgical procedures encourages patients to seek timely medical intervention, thereby reducing the economic burden and enhancing overall treatment outcomes in affected populations.
- Rising Geriatric Population Creates Demand
The increasing elderly population is at a higher risk of gastric volvulus due to age-related factors such as weakened abdominal muscles and decreased elasticity of tissues. This demographic shift fuels the demand for treatment options, as seen in regions such as Japan, where the aging population has led to a surge in gastrointestinal conditions, including gastric volvulus, prompting a greater need for effective therapies. For instance, in the U.S., where the population aged 65 and older is projected to reach 98 million by 2060, there is a corresponding rise in gastric volvulus cases, propelling the demand for advanced treatment options tailored to this demographic.
Restraints/Challenges
- Limited Treatment Options
Limited treatment options, particularly for chronic or recurrent cases, constrain the gastric volvulus treatment market's growth. Current options often involve surgical intervention, but alternatives such as endoscopic or pharmacological approaches are limited. This lack of diverse treatment modalities limits the market's potential for expansion, leaving patients with fewer options for managing this condition effectively.
- High Treatment Costs
The substantial expenses linked with diagnosing, treating, and providing post-operative care for gastric volvulus create financial hurdles for many patients, influencing market demand. These costs encompass diagnostic tests, surgical treatment of gastric volvulus, hospitalization, medication, and follow-up care, making access to treatment challenging for individuals with limited financial resources and impacting the growth of the market.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In December 2021, Pfizer, a US-based pharmaceutical and biotechnology corporation, completed the acquisition of Arena Pharmaceuticals for USD6.7 billion. This strategic move is set to enhance Pfizer's capabilities in inflammation and immunology, fostering the development of novel therapies for patients grappling with immuno-inflammatory disorders
- In December 2020, 9 Meters Biopharma, Inc., a US-based clinical-stage company specializing in addressing rare gastroenterological needs, initiated a Phase 1b/2a trial for NM-002. NM-002, a long-acting GLP-1 receptor agonist leveraging proprietary XTEN technology, aims to ameliorate short bowel syndrome by extending its half-life and modulating gastrointestinal motility to alleviate chronic diarrhea
Gastric Volvulus Treatment Market Scope
The market is segmented on the basis of type, treatment type, drugs, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Organo-Axial Volvulus
- Mesentero-Axial Volvulus
Treatment Type
- Medication
- Surgery
Drugs
- Analgesics
- Antiemetic Agents
- Others
Route of Administration
- Oral
- Parenteral
End- User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
Gastric Volvulus Treatment Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, type, treatment type, drugs, route of administration, end user, and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
Asia-Pacific is expected to show significant growth in the market due to increased research and development activities and robust government support. These factors are projected to drive advancements and accessibility to innovative treatment options, fostering market expansion in the region.
North America is expected to dominate the market due to increased disease incidence, improved healthcare affordability in the U.S., and rising awareness. These factors drive demand for advanced treatment options, positioning the region as a key contributor to market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Gastric Volvulus Treatment Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Sawai Pharmaceutical Co., Ltd (Japan)
- PAI Pharma (U.S.)
- Sun Pharmaceutical Industries Ltd (India)
- ANI Pharmaceuticals, Inc. (U.S.)
- Fresenius SE & Co. KGaA (Germany)
- Mayne Pharma Group Limited (Australia)
- Teva Pharmaceutical Industries Ltd (Israel)
- GLENMARK PHARMACEUTICALS LTD (India)
- Tris Pharma, Inc. (U.S.)
- Pfizer Inc (U.S.)
- Mallinckrodt (U.K.)
- Mylan N.V. (U.S.)
- GSK plc (U.K.)
- Par Pharmaceutical. (U.S.)
- Vintage Labs (India)
- Zydus Group (India)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
